A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/1997
12/10/1997	EP0811385A2 Conjugate of a factor specifically recognizing interleukin-2 receptor with ribonuclease
12/10/1997	EP0811160A1 Nf-kappa b activation regulatory protein, i-kappa b-beta
12/10/1997	EP0811076A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF
12/10/1997	EP0811062A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof
12/10/1997	EP0811061A1 Multiple-tumor aberrant growth genes
12/10/1997	EP0811013A1 Isolated nonapeptides presented by hla molecules, and uses thereof
12/10/1997	EP0811011A1 Carbohydrate conjugated bio-active compounds
12/10/1997	EP0811006A1 Benzopyran-containing compounds and method for their use
12/10/1997	EP0810881A1 Delivery of therapeutic agents by gene therapy
12/10/1997	EP0810878A2 Rna photocleavage using texaphyrins
12/10/1997	EP0810875A1 Multifunctional enzyme
12/10/1997	EP0810870A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
12/10/1997	EP0810866A1 Use of acid-sensitive organo- transition metal compounds in cancer treatment
12/10/1997	EP0440744B1 Products and methods for controlling the suppression of the neoplastic phenotype
12/10/1997	EP0355088B1 Sulphated polysaccharides having anti-metastatic activity
12/10/1997	CN1167505A Tie-2 ligands, methods of making and uses thereof
12/10/1997	CN1167440A Immunotherapeutic stress protein-peptide complexes against cancer
12/10/1997	CN1036652C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present
12/10/1997	CN1036650C Method for prepn. of sulfoamide derivatives
12/09/1997	US5696276 Process for preparing 5,8-dihydroxynaphthoquinone derivatives, novel 5,8-dihydroxynaphthoquinone derivatives and their use as anticancer agent
12/09/1997	US5696248 Gene expression inhibitor, as probes for detecting nucleic acids, as viricides treating viral disease caused by htlv, influenza, hepatitis virus, papilloma virus
12/09/1997	US5696237 Recombinant antibody-toxin fusion protein
12/09/1997	US5696172 Containing complexing agent, preservative and ph adjuster to maintain ph between 7.5 and 8.5 for oxidation resistance and storage stability
12/09/1997	US5696167 4-mercaptobenzoylguanidine derivatives
12/09/1997	US5696154 Brefeldin A derivatives and their utility in the treatment of cancer
12/09/1997	US5696146 3-((2,2-disubstituted-1,3-benzodioxolan-5-yl)methylcarbonyl) indole derivatives; useful for treating acne vulgaris, alpecia, seborrhoea, female hirsutism, benign prostatic hypertrophy and male pattern baldness
12/09/1997	US5696121 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
12/09/1997	US5696108 Protein kinase C inhibitors
12/09/1997	US5696100 Anticancer agent
12/09/1997	US5695932 Telomerase activity assays for diagnosing pathogenic infections
12/09/1997	US5695778 Calcipotriol as active substance
12/09/1997	US5695770 Induction of cytotoxic T-lymphocyte responses
12/09/1997	US5695758 Hybridoma cells
12/09/1997	US5695755 Peripheralization of hematopoietic stem cells
12/09/1997	CA2058935C Pharmaceutical compositions and method for treatment using alzheimer's amyloid peptides
12/06/1997	CA2206914A1 Antibiotic quinolones and derivatives
12/04/1997	WO1997045746A2 Prion protein binding proteins and uses thereof
12/04/1997	WO1997045544A1 Antibodies to the ed-b domain of fibronectin, their construction and uses
12/04/1997	WO1997045450A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy
12/04/1997	WO1997045447A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS
12/04/1997	WO1997045412A1 A method of treating cancer
12/04/1997	WO1997045409A1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
12/04/1997	WO1997045402A1 Phenylsulfonamide derivatives
12/04/1997	WO1997045397A1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
12/04/1997	WO1997045143A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	WO1997045142A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers
12/04/1997	WO1997045137A1 Methods and compositions useful for inhibition of angiogenesis
12/04/1997	WO1997045128A1 Apoptosis associated protein bbk
12/04/1997	WO1997045110A1 Process of preparing 2,2'-(1-methyl-1,2-ethanediylidene)bis[hydrazine carboximidamide]
12/04/1997	WO1997045109A1 Process of preparing 2,2'-(1-methyl-1,2-ethanediylidene)bis[hydrazine carboximidamide]
12/04/1997	WO1997045106A1 Identification of genes altered in multiple myeloma
12/04/1997	WO1997045105A1 Compositions and methods for treating or preventing diseases of body passageways
12/04/1997	WO1997039749A3 Method for the prevention and treatment of cachexia and anorexia
12/04/1997	WO1997038689A3 Enteric-coated pharmaceutical compositions of mycophenolate
12/04/1997	CA2256588A1 Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/04/1997	CA2256481A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	CA2256455A1 Identification of genes altered in multiple myeloma
12/04/1997	CA2256372A1 Apoptosis associated protein bbk
12/04/1997	CA2256312A1 Prion protein binding proteins and uses thereof
12/04/1997	CA2255941A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers
12/04/1997	CA2252606A1 Process of preparing 2,2'-(1-methyl-1,2-ethanediylidene)bis[hydrazine carboximidamide]
12/04/1997	CA2252601A1 Process of preparing 2,2'-(1-methyl-1,2-ethanediylidene)bis¬hydrazine carboximidamide\|
12/03/1997	EP0810285A2 Mutants of human Interleukin-3
12/03/1997	EP0810223A1 Adamantyl substituted oxindoles as pharmaceutical agents
12/03/1997	EP0810206A1 Substituted 2-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicament containing them
12/03/1997	EP0809996A2 Interferon conjugates
12/03/1997	EP0809701A1 Calcineurin regulatable adenylate cyclase
12/03/1997	EP0809698A1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6
12/03/1997	EP0809695A1 Transcription factor - e2f-5
12/03/1997	EP0809655A1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION
12/03/1997	EP0809636A1 Substituted isoxazoles for the treatment of inflammation
12/03/1997	EP0809627A1 Novel borneol derivatives, methods of manufacturing them, and their pharmaceutical use
12/03/1997	EP0809511A1 Inhibition of angiogenesis using interleukin-12
12/03/1997	EP0809510A1 LYMPHOTOXIN-$g(a)/$g(b) COMPLEXES AND ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS
12/03/1997	EP0809499A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
12/03/1997	EP0809493A1 A method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds
12/03/1997	EP0689537B1 Method and apparatus for extracting taxol from source materials
12/03/1997	CN1166858A The tagA gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
12/03/1997	CN1166838A Antibodies against allogenic and Xenogenic proteins, their use in diagnosis and therapy and methods for determination thereof
12/03/1997	CN1166825A Metalloproteinase inhibitors
12/03/1997	CN1166326A Compound selenic-garlic health medicine and its preparation method
12/02/1997	US5693858 Organic salts of N,N'-diacetyl cystine
12/02/1997	US5693844 2-cyano-3-hydroxy-propenamides
12/02/1997	US5693814 Crystals of antimicrobial compound
12/02/1997	US5693776 Nucleic acids specific for Rochalimaea quintana
12/02/1997	US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
12/02/1997	US5693763 Antibodies to human carcinoma antigen
12/02/1997	US5693762 Humanized immunoglobulins
12/02/1997	US5693761 Genetic engineering; complementarity zones
12/02/1997	US5693751 Water soluble high molecular weight polymerized drug preparation
12/02/1997	US5693673 Process of preparing 2,2'-(1-methyl-1,2-ethanediylidene)bis hydrazine caroximidamide!
12/02/1997	US5693666 Used in treating mammalian tumors
12/02/1997	US5693628 11-benzaldoxime-estra-diene derivatives, methods for their production and pharmaceuticals containing these compounds
12/02/1997	US5693627 Use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation
12/02/1997	US5693621 Inhibiting binding of selectin to carbohydrate ligands
12/02/1997	US5693617 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
12/02/1997	US5693612 Used for prophylaxis and treatment of disorders of the circulation, bones and in tumor therapy, and as antimicrobial and antiviral active compounds
12/02/1997	US5693607 Administering to treat fibroproliferative disorders
12/02/1997	US5693522 Anti-cancer immunotherapeutics
12/02/1997	US5693322 Using antibodies that can cross-associate with antibodies on other cells to bring the cells into proximity with one another

1 ... 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 ... 2211